Dupont De Nemours Insider Sold Shares Worth $405,775, According to a Recent SEC Filing-March 2024-www.financetom.com

Dupont De Nemours Insider Sold Shares Worth $405,775, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Dupont De Nemours Insider Sold Shares Worth $405,775, According to a Recent SEC Filing

Jun 4, 2024 1:42 PM

04:26 PM EDT, 06/04/2024 (MT Newswires) -- Jon D. Kemp, President, Electronics & Industrial, on June 03, 2024, sold 5,000 shares in Dupont De Nemours ( DD ) for $405,775. Following the Form 4 filing with the SEC, Kemp has control over a total of 102,004 shares of the company, with 102,004 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1666700/000106299324011826/xslF345X03/form4.xml

Previous page： Vermilion Energy Edges Up After Hours as It Renews Its Normal-Course Issuer Bid Next page： Ultragenyx, Mereo Advance Phase 3 Study of Genetic Bone Disorder Toward Final Analysis

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Vermilion Energy Edges Up After Hours as It Renews Its Normal-Course Issuer Bid

Jul 9, 2025

05:08 PM EDT, 07/09/2025 (MT Newswires) -- Vermilion Energy ( VET ) edged up in after-hours New York trading after the company on Wednesday said it received exchange approvals to renew its normal-course issuer bid for 12 months. The oil and gas producer it can buy back and cancel up to 15.26-million shares in the year beginning July 12, 10%...

Ultragenyx, Mereo Advance Phase 3 Study of Genetic Bone Disorder Toward Final Analysis

Jul 9, 2025

05:11 PM EDT, 07/09/2025 (MT Newswires) -- Ultragenyx (RARE) and Mereo BioPharma ( MREO ) said Wednesday that the placebo-controlled portion of a pivotal phase 3 study of UX143 (setrusumab) for osteogenesis imperfecta is advancing to final analysis as planned, with data expected by year-end. The study's independent data monitoring committee affirmed that the candidate maintains an acceptable safety profile,...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Choice Hotels International Insider Sold Shares Worth $650,328, According to a Recent SEC Filing

Jul 9, 2025

05:08 PM EDT, 07/09/2025 (MT Newswires) -- Dominic Dragisich, Executive Vice President, Operations and Chief Global Brand Officer, on July 08, 2025, sold 4,900 shares in Choice Hotels International ( CHH ) for $650,328. Following the Form 4 filing with the SEC, Dragisich has control over a total of 70,881 common shares of the company, with 70,881 shares held directly....